Support By : Li-lab
| PATHWAY_NAME | REACTOME_ID | KEGG_ID | DRUG_NAME | PUBCHEM_CID | Datasource |
|---|---|---|---|---|---|
| Basal transcription factors | R-HSA-3232118 | map03022 | (-)-catechin | 192197 | drug-path |
| Glioma | Q9NZM4 | map05214 | demecolcine | 37393 | drug-path |
| Epithelial cell signaling in Helicobacter pylori infection | 0 | map05120 | demecolcine | 37393 | drug-path |
| Vibrio cholerae infection | R-HSA-9609646 | map05110 | demecolcine | 37393 | drug-path |
| Non-small cell lung cancer | R-HSA-5619066 | map05223 | demecolcine | 37393 | drug-path |
| Gap junction | R-HSA-190861 | map04540 | demecolcine | 37393 | drug-path |
| T cell receptor signaling pathway | R-HSA-983705 | map04660 | troglitazone | 5591 | drug-path |
| Focal adhesion | R-HSA-354113 | map04510 | troglitazone | 5591 | drug-path |
| Systemic lupus erythematosus | R-HSA-977105 | map05322 | troglitazone | 5591 | drug-path |
| Non-small cell lung cancer | R-HSA-5619066 | map05223 | troglitazone | 5591 | drug-path |
| ECM-receptor interaction | R-HSA-373711 | map04512 | troglitazone | 5591 | drug-path |
| Neuroactive ligand-receptor interaction | R-HSA-5632681 | map04080 | troglitazone | 5591 | drug-path |
| Insulin signaling pathway | R-HSA-74752 | map04910 | rosiglitazone | 77999 | drug-path |
| Olfactory transduction | R-HSA-9751605 | map04740 | rosiglitazone | 77999 | drug-path |
| Systemic lupus erythematosus | R-HSA-977105 | map05322 | rosiglitazone | 77999 | drug-path |
| Tight junction | R-HSA-2134514 | map04530 | rosiglitazone | 77999 | drug-path |
| Parkinson's disease | R-HSA-1643685 | 0 | rosiglitazone | 77999 | drug-path |
| Neuroactive ligand-receptor interaction | R-HSA-5632681 | map04080 | rosiglitazone | 77999 | drug-path |
| Epithelial cell signaling in Helicobacter pylori infection | 0 | map05120 | rosiglitazone | 77999 | drug-path |
| VEGF signaling pathway | R-HSA-194138 | map04370 | rosiglitazone | 77999 | drug-path |